Search
Search Constraints
You searched for: Is Part Of European journal of radiology. Issue 130(2020)Limit your search
- 616.075705 54
- Medical radiology 54
- Medical radiology -- Periodicals 54
- Periodicals 54
- Radiologie médicale -- Périodiques 54
- Radiology -- Periodicals 54
- 3D-models -- Filtration -- MSCT -- GFR -- Split renal function assessment -- Renal scintigraphy 1
- ADC apparent diffusion coefficient -- CNR contrast-to-noise ratio -- csPCa clinically significant prostate cancer -- CSR cancer suspect region -- DCE dynamic contrast-enhanced imaging -- DWI diffusion-weighted imaging -- EPI echo-planar imaging -- FOV field-of-view -- IQ image quality -- IQR interquartile range -- iShim-DWI single-shot technique applying slice-specific shimming -- mp-MRI multiparametric magnetic resonance imaging -- PCa prostate cancer -- PI-RADS Prostate Imaging Reporting and Data System, version 2/2.1 -- PSA prostate specific antigen -- ptx-EPI parallel-transmit echo-planar imaging -- PZ peripheral zone -- RESOLVE REadout Segmentation Of Long Variable Echo trains -- ROI region of interest -- rs-EPI readout-segmented multi-shot echo-planar imaging -- SD standard deviation -- SI signal intensity -- SNR signal-to-noise ratio -- ss-EPI single-shot echo-planar imaging -- TZ transition zone -- ZOOMit Zoomed imaging with parallel transmission technique 1
- AIDR 3D enhanced adaptive iterative dose reduction 3-dimensional enhanced -- CNR contrast-to-noise ratio -- CTU CT urography -- FIRST forward projected model-based iterative reconstruction solution -- ICC intraclass correlation coefficient -- IR iterative reconstruction -- MIP maximum intensity projection -- ROI region of interest -- SD standard deviation -- SHR super high-resolution -- U-HRCT ultra-high-resolution CT 1
- ALND axillary lymph node dissection -- AUC area under the curve -- AUS axillary ultrasound -- CI confidence interval -- ER estrogen receptor -- HER2 human epidermal growth factor receptor 2 -- HIPAA Health Insurance Portability and Accountability Act -- IHC immunohistochemical -- IRB institutional review board -- NAST neoadjuvant systemic therapy -- NPV negative predictive value -- pCR pathologic complete response -- PPV positive predictive value -- PR progesterone receptor -- RCB residual cancer burden -- SLNB sentinel lymph node biopsy -- SD standard deviation -- TAD targeted axillary dissection -- TNBC triple-negative breast cancer 1